EW - Edwards Lifesciences Corp
Edwards Lifesciences Corp Logo

EW - Edwards Lifesciences Corp

https://www.edwards.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Uptrend
As of 2025-09-09 (Snapshot)

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

52W High
$83.00
52W Low
$64.01

MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.07
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
33.87
Forward P/E (<15 better)
29.41
EV/EBITDA (<8 favorable)
24.16
EV/Revenue (<3 favorable)
7.77
P/S (TTM) (<3 favorable)
8.36
P/B (<3 favorable)
4.51
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.91%
Institutions (25–75% balanced)
88.25%
Shares Outstanding
587,100,000
Float
581,106,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
5,685,100,000
Gross Profit (TTM)
4,484,000,000
EPS (TTM)
2.39
Profit Margin (>10% good)
0.73%
Operating Margin (TTM) (higher better)
0.28%
ROE (TTM) (>15% strong)
0.16%
EPS YoY (Quarterly) (>10% good)
-0.08
Revenue YoY (Quarterly) (>8% good)
0.12
Momentum
Bearish momentum
Value
0.6307
Previous
0.7973
Trend
Falling
Signal Cross
No cross

As of
Sep. 09, 2025